4 IN VITRO IN VIVO AGENT DEVELOPMENT ASSAYS: EVALUATION OF GLG-302, A STAT3 ANTAGONIST, IN THE PREVENTION OF MAMMARY CANCER; HHSN261201200021I - TASK ORDER NUMBER: HHSN26100004 - UNIVERSITY OF ALABAMA AT BIRMINGHAM - PERIOD OF PERFORMANCE: 09/18/2013 - 09/17/2016 Close Out ($3k) 9/18/17 3 IN VITRO IN VIVO AGENT DEVELOPMENT ASSAYS: EVALUATION OF GLG-302, A STAT3 ANTAGONIST, IN THE PREVENTION OF MAMMARY CANCER; HHSN261201200021I - TASK ORDER NUMBER: HHSN26100004 - UNIVERSITY OF ALABAMA AT BIRMINGHAM - PERIOD OF PERFORMANCE: 09/18/2013 - 09/17/2015 Other Administrative Action $0 8/21/15 2 IN VITRO IN VIVO AGENT DEVELOPMENT ASSAYS: EVALUATION OF GLG-302, A STAT3 ANTAGONIST, IN THE PREVENTION OF MAMMARY CANCER; HHSN261201200021I - TASK ORDER NUMBER: HHSN26100004 - UNIVERSITY OF ALABAMA AT BIRMINGHAM - PERIOD OF PERFORMANCE: 09/18/2013 - 09/17/2015 Other Administrative Action $0 5/7/15 1 IN VITRO IN VIVO AGENT DEVELOPMENT ASSAYS: EVALUATION OF GLG-302, A STAT3 ANTAGONIST, IN THE PREVENTION OF MAMMARY CANCER; HHSN261201200021I - TASK ORDER NUMBER: HHSN26100004 - UNIVERSITY OF ALABAMA AT BIRMINGHAM - PERIOD OF PERFORMANCE: 09/18/2013 - 09/17/2015 Other Administrative Action $0 2/27/15 Not listed IN VITRO IN VIVO AGENT DEVELOPMENT ASSAYS: EVALUATION OF GLG-302, A STAT3 ANTAGONIST, IN THE PREVENTION OF MAMMARY CANCER; HHSN261201200021I - TASK ORDER NUMBER: HHSN26100004 - UNIVERSITY OF ALABAMA AT BIRMINGHAM - PERIOD OF PERFORMANCE: 09/18/2013 - 09/17/2015 Not listed $395.9k 9/13/13